Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 59,000 shares at $0.14 ($6K) on 2016-07-07, disclosed to the SEC on 2016-07-07.
Open-market purchase of $6k LXRP by CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.09 | 50,000 | $5K | 80.9% |
| 2 | $0.10 | 5,000 | $500 | 9.0% |
| 3 | $0.14 | 4,000 | $560 | 10.1% |
| Total | $0.09 avg | 59,000 | $6K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |